Trader’s Recap: Facebook Inc (NASDAQ:FB), PrimeCare Systems Inc (OTCMKTS:PCYS), Acceleron Pharma Inc (NASDAQ:XLRN), Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Facebook Inc (NASDAQ:FB), reportedly has plans of opening an office in Beijing as well for which it is working quite fast and has acquired a premium office space on rent as reported on Monday by Beijing Youth Daily. The office space is rented for three-years and is located in a prime location at Beijing central business district. The newspaper, citing a source from the property developer, claims that the rented space is located in Fortune Financial Center. Facebook Inc (NASDAQ:FB), net profit margin is 21.40% and weekly performance is -6.73%. On last trading day company shares ended up $62.76. Analysts mean target price for the company is $77.83. Facebook Inc (NASDAQ:FB), distance from 50-day simple moving average (SMA50) is 0.53%.

PrimeCare Systems Inc (OTCMKTS:PCYS), in last trading session ended the day on $0.0007.

On May 21, 2014, Acceleron Pharma Inc (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease. Acceleron Pharma Inc (NASDAQ:XLRN), shares moved down 7.34% in last trading session and was closed at $29.04, while trading in range of $28.88 – 31.41. Acceleron Pharma Inc (NASDAQ:XLRN),year to date (YTD) performance is -26.67%.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN), major shareholder Sanofi bought 356,700 shares of the stock on the open market in a transaction dated Monday, July 7th. The shares were purchased at an average price of $312.37 per share, with a total value of $111,422,379.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC. Regeneron Pharmaceuticals Inc (NASDAQ:REGN), ended the last trading day at $310.52. Company weekly volatility is calculated as 3.46% and price to cash ratio as 48.33. Regeneron Pharmaceuticals Inc (NASDAQ:REGN), showed a negative weekly performance of 9.93%.